Hojjat Ahmadzadehfar

Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany|Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

[ 1 ] - The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA

Prostate-specific membrane antigen (PSMA) is a type II transmembrane protein, which is anchored in the cell membrane of prostate epithelial cells. It is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer. Although, 177Lu-PSMA has been recently introduced for radionuclide therapy of metastatic castration-resistant prostate cancer (mCRPC) with co...

Co-Authors

Babak Fallahi 1  

Babak Shafiei 1  

Elahe Pirayesh 1  

Kamran Aryana 1  

Mahasti Amoui 1  

Majid Assadi 1  

Narjess Ayati 1  

Saeed Farzanehfar 1